| pubmed-article:20064220 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20064220 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:20064220 | lifeskim:mentions | umls-concept:C0021390 | lld:lifeskim |
| pubmed-article:20064220 | lifeskim:mentions | umls-concept:C0005527 | lld:lifeskim |
| pubmed-article:20064220 | lifeskim:mentions | umls-concept:C1521801 | lld:lifeskim |
| pubmed-article:20064220 | pubmed:dateCreated | 2010-2-10 | lld:pubmed |
| pubmed-article:20064220 | pubmed:abstractText | Infliximab is usually administered by two monthly intravenous (iv) infusions, therefore requiring visits to hospital. Adalimumab is administered by self subcutaneous (sc) injections every other week. Both of these anti-TNF drugs appear to be equally efficacious in the treatment of Crohn's Disease and therefore the decision regarding which drug to choose will depend to some extent on patient choice, which may be based on the mode of administration.The aims of this study were to compare preferences in Inflammatory Bowel Disease (IBD) patients for two currently available anti-TNF agents and the reasons for their choices. | lld:pubmed |
| pubmed-article:20064220 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20064220 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20064220 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20064220 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20064220 | pubmed:issn | 1471-230X | lld:pubmed |
| pubmed-article:20064220 | pubmed:author | pubmed-author:AllenPatrick... | lld:pubmed |
| pubmed-article:20064220 | pubmed:author | pubmed-author:ThamTony C... | lld:pubmed |
| pubmed-article:20064220 | pubmed:author | pubmed-author:LindsayHannah... | lld:pubmed |
| pubmed-article:20064220 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20064220 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:20064220 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20064220 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20064220 | pubmed:pagination | 1 | lld:pubmed |
| pubmed-article:20064220 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:20064220 | pubmed:meshHeading | pubmed-meshheading:20064220... | lld:pubmed |
| pubmed-article:20064220 | pubmed:meshHeading | pubmed-meshheading:20064220... | lld:pubmed |
| pubmed-article:20064220 | pubmed:meshHeading | pubmed-meshheading:20064220... | lld:pubmed |
| pubmed-article:20064220 | pubmed:meshHeading | pubmed-meshheading:20064220... | lld:pubmed |
| pubmed-article:20064220 | pubmed:meshHeading | pubmed-meshheading:20064220... | lld:pubmed |
| pubmed-article:20064220 | pubmed:meshHeading | pubmed-meshheading:20064220... | lld:pubmed |
| pubmed-article:20064220 | pubmed:meshHeading | pubmed-meshheading:20064220... | lld:pubmed |
| pubmed-article:20064220 | pubmed:meshHeading | pubmed-meshheading:20064220... | lld:pubmed |
| pubmed-article:20064220 | pubmed:meshHeading | pubmed-meshheading:20064220... | lld:pubmed |
| pubmed-article:20064220 | pubmed:meshHeading | pubmed-meshheading:20064220... | lld:pubmed |
| pubmed-article:20064220 | pubmed:meshHeading | pubmed-meshheading:20064220... | lld:pubmed |
| pubmed-article:20064220 | pubmed:meshHeading | pubmed-meshheading:20064220... | lld:pubmed |
| pubmed-article:20064220 | pubmed:meshHeading | pubmed-meshheading:20064220... | lld:pubmed |
| pubmed-article:20064220 | pubmed:meshHeading | pubmed-meshheading:20064220... | lld:pubmed |
| pubmed-article:20064220 | pubmed:meshHeading | pubmed-meshheading:20064220... | lld:pubmed |
| pubmed-article:20064220 | pubmed:meshHeading | pubmed-meshheading:20064220... | lld:pubmed |
| pubmed-article:20064220 | pubmed:meshHeading | pubmed-meshheading:20064220... | lld:pubmed |
| pubmed-article:20064220 | pubmed:meshHeading | pubmed-meshheading:20064220... | lld:pubmed |
| pubmed-article:20064220 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20064220 | pubmed:articleTitle | How do patients with inflammatory bowel disease want their biological therapy administered? | lld:pubmed |
| pubmed-article:20064220 | pubmed:affiliation | Division of Gastroenterology, Ulster Hospital, Dundonald, Belfast, N Ireland BT16 1RH, UK. paddyallen8@hotmail.com | lld:pubmed |
| pubmed-article:20064220 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20064220 | pubmed:publicationType | Comparative Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20064220 | lld:pubmed |
